BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1424006)

  • 1. Rejection after cardiac transplantation. A time-related risk factor analysis.
    Kirklin JK; Naftel DC; Bourge RC; White-Williams C; Caulfield JB; Tarkka MR; Holman WL; Zorn GL
    Circulation; 1992 Nov; 86(5 Suppl):II236-41. PubMed ID: 1424006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group.
    Kubo SH; Naftel DC; Mills RM; O'Donnell J; Rodeheffer RJ; Cintron GB; Kenzora JL; Bourge RC; Kirklin JK
    J Heart Lung Transplant; 1995; 14(3):409-18. PubMed ID: 7654724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
    J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
    Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.
    Kobashigawa JA; Kirklin JK; Naftel DC; Bourge RC; Ventura HO; Mohanty PK; Cintron GB; Bhat G
    J Heart Lung Transplant; 1993; 12(3):355-66. PubMed ID: 8329404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
    J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience.
    Chin C; Naftel DC; Singh TP; Blume ED; Luikart H; Bernstein D; Gamberg P; Kirklin JK; Morrow WR;
    J Heart Lung Transplant; 2004 Feb; 23(2):178-85. PubMed ID: 14761765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria].
    Colombo T; Borrello B; Lanfranconi M; Pomé G; Quaini E; Russo C; Vitali E; Grassi M; Frigerio M; Gronda E; Mangiavacchi M; Merli M; Pellegrini A
    G Ital Cardiol; 1997 Jan; 27(1):3-18. PubMed ID: 9244710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of late allograft nephrectomy.
    Madore F; Hébert MJ; Leblanc M; Girard R; Bastien E; Morin M; Beaudry C; Boucher A; Dandavino R
    Clin Nephrol; 1995 Nov; 44(5):284-9. PubMed ID: 8605707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
    Higgins R; Kirklin JK; Brown RN; Rayburn BK; Wagoner L; Oren R; Miller L; Flattery M; Bourge RC;
    J Heart Lung Transplant; 2005 Apr; 24(4):392-400. PubMed ID: 15797738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of acute graft rejection on calcineurin inhibitor-free immunosuppression after heart transplantation.
    Celik S; Doesch AO; Konstandin MH; Kristen AV; Ammon K; Sack FU; Schnabel P; Katus HA; Dengler TJ
    Transplant Proc; 2011 Jun; 43(5):1862-7. PubMed ID: 21693290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.
    Kobashigawa J; David K; Morris J; Chu AH; Steffen BJ; Gotz VP; Gordon RD
    Transplant Proc; 2005 Mar; 37(2):1333-9. PubMed ID: 15848713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.